{'fraction_non_alphanumeric': 0.02734375, 'fraction_numerical': 0.013671875, 'mean_word_length': 4.896551724137931, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Gene doping: Olympic genes for Olympic dreams

As we approach the London 2012 Olympics, sport finds itself facing a highly specific threat to its ethos of fair play. Defined by the World Anti-Doping Agency (WADA) as ‘the non-therapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance’,1 gene doping presents a range of challenges to those involved in sport and exercise medicine and an urgent need for an understanding of its potential impact to healthcare.2,3